| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Atea Pharmaceuticals, Inc.
13G/A
Amendment 5
AVIR · 04683R106
|
11.0% |
11/13/2026
Event 9/30/2026
|
|||
| JPM Partners LLC | 6.4% | ||||
| Jean-Pierre Sommadossi | 11.0% | ||||
|
Atea Pharmaceuticals, Inc.
13G/A
Amendment 4
AVIR · 04683R106
|
10.1% |
5/14/2025
Event 3/31/2025
|
|||
| JPM Partners LLC | 6.9% | ||||
| Jean-Pierre Sommadossi | 10.1% | ||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.